SEC Filings for Anika Therapeutics Inc. (ANIK)

$ 42.57   0.16 (+0.38%) Volume: 146.76k 4:00 PM EST 19-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
DEFR14ARevised definitive proxy soliciting materials605/24/2016
4Statement of changes in beneficial ownership of securities105/10/2016
10-QGeneral form for quarterly reports under Section 13 or 15(d)5905/03/2016
8-KCurrent report pursuant to Section 13 or 15(d)804/27/2016
DEFA14AAdditional proxy soliciting materials - definitive504/20/2016
DEF 14AOther definitive proxy statements3704/20/2016
4Statement of changes in beneficial ownership of securities104/06/2016
3Initial statement of beneficial ownership of securities204/06/2016
3Initial statement of beneficial ownership of securities204/06/2016
4Statement of changes in beneficial ownership of securities104/06/2016
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote3604/06/2016
8-KCurrent report pursuant to Section 13 or 15(d)304/04/2016
10-KAnnual report pursuant to Section 13 or 15(d)7503/10/2016
8-KCurrent report pursuant to Section 13 or 15(d)303/02/2016
4Statement of changes in beneficial ownership of securities102/29/2016
5678910111213141516171819